These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 28238951)
21. New pathways driving the experimental hepatoprotective action of tempol (4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl) against acute hepatotoxicity. Abdel-Hamid NM; Wahid A; Mohamed EM; Abdel-Aziz MA; Mohafez OM; Bakar S Biomed Pharmacother; 2016 Apr; 79():215-21. PubMed ID: 27044831 [TBL] [Abstract][Full Text] [Related]
22. Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration. de Oliveira DM; de Oliveira EM; Ferrari Mde F; Semedo P; Hiyane MI; Cenedeze MA; Pacheco-Silva A; Câmara NO; Peron JP Inflammopharmacology; 2015 Dec; 23(6):343-54. PubMed ID: 26559850 [TBL] [Abstract][Full Text] [Related]
23. Cinnamon ameliorates experimental allergic encephalomyelitis in mice via regulatory T cells: implications for multiple sclerosis therapy. Mondal S; Pahan K PLoS One; 2015; 10(1):e0116566. PubMed ID: 25569428 [TBL] [Abstract][Full Text] [Related]
24. Physical Exercise Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Peripheral Immune Response and Blood-Brain Barrier Disruption. Souza PS; Gonçalves ED; Pedroso GS; Farias HR; Junqueira SC; Marcon R; Tuon T; Cola M; Silveira PCL; Santos AR; Calixto JB; Souza CT; de Pinho RA; Dutra RC Mol Neurobiol; 2017 Aug; 54(6):4723-4737. PubMed ID: 27447807 [TBL] [Abstract][Full Text] [Related]
25. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation. Ingwersen J; Wingerath B; Graf J; Lepka K; Hofrichter M; Schröter F; Wedekind F; Bauer A; Schrader J; Hartung HP; Prozorovski T; Aktas O J Neuroinflammation; 2016 Feb; 13():48. PubMed ID: 26920550 [TBL] [Abstract][Full Text] [Related]
26. Exploiting the Therapeutic Potential of Endogenous Immunomodulatory Systems in Multiple Sclerosis-Special Focus on the Peroxisome Proliferator-Activated Receptors (PPARs) and the Kynurenines. Fakan B; Szalardy L; Vecsei L Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30669473 [TBL] [Abstract][Full Text] [Related]
27. The type IV phosphodiesterase specific inhibitor mesopram inhibits experimental autoimmune encephalomyelitis in rodents. Dinter H; Tse J; Halks-Miller M; Asarnow D; Onuffer J; Faulds D; Mitrovic B; Kirsch G; Laurent H; Esperling P; Seidelmann D; Ottow E; Schneider H; Tuohy VK; Wachtel H; Perez HD J Neuroimmunol; 2000 Aug; 108(1-2):136-46. PubMed ID: 10900347 [TBL] [Abstract][Full Text] [Related]
29. A novel PADRE-Kv1.3 vaccine effectively induces therapeutic antibodies and ameliorates experimental autoimmune encephalomyelitis in rats. Fan C; Long R; You Y; Wang J; Yang X; Huang S; Sheng Y; Peng X; Liu H; Wang Z; Liu K Clin Immunol; 2018 Aug; 193():98-109. PubMed ID: 29496642 [TBL] [Abstract][Full Text] [Related]
30. Induction of endogenous Type I interferon within the central nervous system plays a protective role in experimental autoimmune encephalomyelitis. Khorooshi R; Mørch MT; Holm TH; Berg CT; Dieu RT; Dræby D; Issazadeh-Navikas S; Weiss S; Lienenklaus S; Owens T Acta Neuropathol; 2015 Jul; 130(1):107-18. PubMed ID: 25869642 [TBL] [Abstract][Full Text] [Related]
31. The combination of either tempol or FK506 with delayed hypothermia: implications for traumatically induced microvascular and axonal protection. Fujita M; Oda Y; Wei EP; Povlishock JT J Neurotrauma; 2011 Jul; 28(7):1209-18. PubMed ID: 21521034 [TBL] [Abstract][Full Text] [Related]
32. Immunomodulation neuroprotection and remyelination - the fundamental therapeutic effects of glatiramer acetate: a critical review. Aharoni R J Autoimmun; 2014 Nov; 54():81-92. PubMed ID: 24934599 [TBL] [Abstract][Full Text] [Related]
33. Ageing and recurrent episodes of neuroinflammation promote progressive experimental autoimmune encephalomyelitis in Biozzi ABH mice. Peferoen LA; Breur M; van de Berg S; Peferoen-Baert R; Boddeke EH; van der Valk P; Pryce G; van Noort JM; Baker D; Amor S Immunology; 2016 Oct; 149(2):146-56. PubMed ID: 27388634 [TBL] [Abstract][Full Text] [Related]
34. Impact of Minocycline on Extracellular Matrix Metalloproteinase Inducer, a Factor Implicated in Multiple Sclerosis Immunopathogenesis. Hahn JN; Kaushik DK; Mishra MK; Wang J; Silva C; Yong VW J Immunol; 2016 Nov; 197(10):3850-3860. PubMed ID: 27733550 [TBL] [Abstract][Full Text] [Related]
35. Neuroprotection by the stable nitroxide Tempol during reperfusion in a rat model of transient focal ischemia. Rak R; Chao DL; Pluta RM; Mitchell JB; Oldfield EH; Watson JC J Neurosurg; 2000 Apr; 92(4):646-51. PubMed ID: 10761655 [TBL] [Abstract][Full Text] [Related]
36. Beneficial Effect of Tempol, a Membrane-Permeable Radical Scavenger, on Inflammation and Osteoarthritis in In Vitro Models. Calabrese G; Ardizzone A; Campolo M; Conoci S; Esposito E; Paterniti I Biomolecules; 2021 Feb; 11(3):. PubMed ID: 33669093 [TBL] [Abstract][Full Text] [Related]
37. Hair Follicle Damage after 100 mGy Low-Dose Fractionated X-Ray Irradiation and the Protective Effects of TEMPOL, a Stable Nitroxide Radical, against Radiation. Kawabata Y; Fukushige T; Indo HP; Matsumoto KI; Ueno M; Nakanishi I; Chatatikun M; Klangbud WK; Surinkaew S; Tangpong J; Kanekura T; Majima HJ Radiat Res; 2024 Feb; 201(2):115-125. PubMed ID: 38211765 [TBL] [Abstract][Full Text] [Related]
38. Safinamide and flecainide protect axons and reduce microglial activation in models of multiple sclerosis. Morsali D; Bechtold D; Lee W; Chauhdry S; Palchaudhuri U; Hassoon P; Snell DM; Malpass K; Piers T; Pocock J; Roach A; Smith KJ Brain; 2013 Apr; 136(Pt 4):1067-82. PubMed ID: 23518709 [TBL] [Abstract][Full Text] [Related]
39. Preclinical Therapy with Vitamin D3 in Experimental Encephalomyelitis: Efficacy and Comparison with Paricalcitol. Mimura LAN; Fraga-Silva TFC; Oliveira LRC; Ishikawa LLW; Borim PA; Machado CM; Júnior JACEH; Fonseca DMD; Sartori A Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671896 [TBL] [Abstract][Full Text] [Related]